PharmAla completes release testing on first Australian-made LaNeo MDMA capsules

PharmAla Biotech Holdings Inc. (MDMA) — PharmAla Biotech announced it completed release testing on its first batch of LaNeo MDMA 40 mg capsules manufactured in Australia, a step toward localizing supply for the country's Authorised Prescriber scheme.

Domestic Australian production could shorten supply chains and strengthen PharmAla's position as a commercial MDMA supplier in the world's only market that regulates MDMA as a prescribable medicine.

Source: globenewswire.com

For the rest of that week's sector news, read our week in review.